michigan semaglutide gastrointestinal obstruction lawsuit digestive blockage class action Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) filed against louisiana semaglutide pancreatitis law firm

Drug interactions with cisapride: clinical implications

[28] [29] However, there is currently no robust clinical trial evidence specifically examining GLP-1 medications for hot flash management, and no official link has been established between GLP-1 therapy and vasomotor symptom improvement

This includes any possible side effects not listed in the package leaflet

When discussing mounjaro vs zepbound, both medications contain the same active ingredient, tirzepatide, but Mounjaro is approved for diabetes management, while Zepbound is approved for weight management

Semaglutide also enhances glucose-dependent insulin secretion from the pancreas